Skip to main content

Table 2 Laboratory findings of pediatric patients hospitalized with COVID-19, Tehran, Iran, 2020 on admission

From: Children with SARS-CoV-2 infection during the novel coronaviral disease (COVID-19) outbreak in Iran: an alarming concern for severity and mortality of the disease

Parameter

Acute COVID-19 (without MIS-C)

MIS-C

Non-severe

Severe

Discharged

Died

Median (IQR)

Median (IQR)

Median (IQR)

Median (IQR)

Median (IQR)

Median (IQR)

Age (years)

4 (1.1–10)

8 (1.6–8)

6 (2–10)

3.5 (0.6–8.5)

5 (1.6–10)

4 (0.4–11.7)

White blood cell count (× 109 cells per L)

8.6 (5.6–12.1)

6.6 (4.8–9.6)

7.6 (5.6–11.8)

9.6 (4.7–12.1)

8 (5.3–11.7)

9.3 (3.7–15.1)

Neutrophil count (× 109 cells per L)

4.9 (2.5–8.4)

4.1 (2.6–7.5)

4.6 (2.5–7.6)

5.5 (2.4–9)

5 (2.5–8.2)

4.3 (2.8–8.9)

Lymphocyte count (× 109 cells per L)

1.9 (1.1–3.3)

1.2 (0.7–2.3)

1.7 (1.1–3.4)

3 (2–3.3)

1.8 (1.1–3.1)

3.4 (0.5–5.2)

Haemoglobin (g/dL)

11.7 (9.7–13.1)

12.3 (10.7–13.2)

11.9 (10.7–13.2)

11.4 (9.3–12.9)

11.9 (10.2–13.2)

10.4 (8.4–12)

Platelet count (× 109 cells per L)

268 (173–380)

258 (99–316)

273 (219–382)

231 (116–353)

274 (191–381)

148.5 (41–302)

Oximetry saturation (%)

90.4 (78–97)

90.3 (86.5–94.7)

89.6 (77.9–97.1)

92.2 (81.2–97.2)

90.4 (78–97)

90.9 (82–98)

Urea (mmol/L)

12 (8–15)

10 (8–17)

12 (9–15)

10 (7–15.5)

11 (1.1–3.1)

20 (11–26.2)

Creatinine (µmol/L)

0.6 (0.4–0.7)

0.5 (0.5–0.6)

0.6 (0.5–0.7)

0.5 (0.3–0.6)

0.5 (0.5–1.4)

0.5 (0.3–0.92)

Creatine phosphokinase (U/L)

61 (33–101)

69 52–279)

67.5 (37.5–100)

51 (31–115.5)

64 (36–101)

51 (30.5–371.5)

Lactate dehydrogenase (U/L)

557 (408–727)

671 (598–869)

527(383–663.5)

680(531.5–984)

550 (400–708)

1121 (700–1617)

Calcium (mg/dL)

8.9 (8.5–9.5)

8.5 (8.1–9.3)

9.1 (8.4–9.5)

8.7 (8.3–9.3)

8.9 (8.5–9.4)

8.6 (8.3–9.6)

Phosphorus (mg/dL)

4.2 (3.8–4.9)

4.1 (3.6–4.6)

4.1 (3.7–4.8)

4.5 (3.7–5.1)

4.2 (3.7–5.1)

4.3 (3.8–4.8)

Magnesium (mg/dL)

1.9 (1.7–2.1)

2.1 (1.9–2.4)

1.9 (1.7–2.1)

1.9 (1.7–2.2)

1.9 (1.8–2.1)

1.8 (1.6–2.4)

Sodium (meq/L)

135 (132–138)

134.5 (133–137)

136 (133–138)

134 (131–137.5)

136 (133–138)

133 (131–136.5)

Potassium (meq/L)

4.1 (3.9–4.5)

3.9 (3.8–4.5)

4.1 (3.9–4.5)

4.2 (3.9–4.6)

4.1 (3.9–4.5)

4.4 (4–4.7)

Prothrombin time (s)

13.3 (12.5–14)

12.8 (12.5–14)

13.2 (12.5–14)

13.7 (12.5–14.7)

13.3 (12.5–14)

14.6 (13.3–19.2)

Partial thromboplastin time (s)

33 (30–38)

34 (33–40)

33 (30–37)

34 (31–41.5)

33 (30–37.7)

35 (31–41.5)

International normalized ratio (mm/h)

1.1 (1–1.2)

1 (1–1.2)

1.1 (1–1.2)

1 (1.1–1.3)

1.1 (1–1.2)

1.1 (1.1–1.97)

C-reactive protein (mg/L)

18 (5–44.5)

19 (4–54)

17.5 (4–42.5)

19.5 (6.7–49.2)

13 (4–42)

43 (24.5–109)

Erythrocyte sedimentation rate

24 (12–44.7)

24 (12–46)

21 (12–44)

27 (10.2–51.5)

23 (12–44)

26 (3–90)

Alanine aminotransferase (U/L)

32 (22–39.5)

35 (27–124)

26.5 (21.2–37.7)

34.5 (29–60.5)

30 (22–40)

34 (21.5–205.5)

Aspartate aminotransferase (U/L)

21 (13–41.5)

23 (14–78)

20.5 (13–39)

24.5 (15.2–72.7)

22 (13–40)

29 (16–80)

Procalcitonin (ng/mL)

0.02 (0.01–0.3)

0.1 (0.02–0.5)

0.02 (0.01–0.27)

0.02 (0.01–0.77)

0.02 (0.01–0.27)

2 (0.02–10)

Albumin (g/dL)

4 (3.4–4.5)

4.4 (4.1–4.4)

4.3 (3.9–4.5)

3.7 (3.1–4.3)

4.2 (3.6–4.5)

3.6 (2.7–4)

Fibrinogen (mg/dL)

323 (203–490)

411 (225–606)

427 (225.5–534.5)

296 (202.5–490)

395.5 (244–498)

296 (80–605)

Ferritin (ng/mL)

193 (101–546)

135 (91–353)

147 (91–359)

460 (131–1310)

188 101–512)

1890 (76–2490)

d-Dimer (pg/mL)

0.9 (0.38–6)

1.8 (1.7–1.8)

3.95 (1.7–264)

0.7 (0.3–3.1)

1.7 (0.6–4.5)

1.8 (0.2–7785)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us